16.4% SODIUM ACETATE INJECTION, USP
16.4% SODIUM ACETATE INJECTION, USP
Discontinued
DIN Number
02247204
Drug Class
Human
Market Date
Feb 13, 2003
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02247204
AIG Number0113986002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA08 SODIUM ACETATE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
SODIUM ACETATEActive
Strength: 16.4 %
Monograph: SODIUM ACETATE